Robert Koski - Dec 29, 2022 Form 4 Insider Report for ORAGENICS INC (OGEN)

Role
Director
Signature
/s/ Mark A. Catchur, as Attorney-in-Fact for Robert C. Koski
Stock symbol
OGEN
Transactions as of
Dec 29, 2022
Transactions value $
-$8,353
Form type
4
Date filed
1/3/2023, 03:20 PM
Previous filing
Dec 15, 2022
Next filing
Aug 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OGEN Common Stock Sale -$3.88K -36.6K -17.22% $0.11 176K Dec 29, 2022 Direct F1, F2
transaction OGEN Common Stock Sale -$4.47K -42.4K -3.7% $0.11 1.1M Dec 30, 2022 See footnote F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The prices reported in Column 4 were the weighted average prices on the Transaction Dates indicated. The shares were sold in multiple transactions ranging from $0.1020 to $0.1121 and $0.1026 to $0.1096 on each Transaction Date, respectively. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F2 Shares owned directly by Robert C. Koski, a director of the Company.
F3 Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.